All treatments
Treatment
Ritlecitinib higher dose clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruitingPHASE3
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
This study is looking into a new medicine called ritlecitinib for children aged 6 to 11 with severe alopecia areata, a condition that causes hair loss. It aims to see if the medicine is safe and helps hair regrow. Participants will take a capsule daily for 6 months.
For: Severe Alopecia AreataUnited States · China · Czechia - RecruitingPHASE3
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
This study looks at a medicine called ritlecitinib for children with severe alopecia areata, a condition causing hair loss. It checks if the medicine is safe and works over a long time for children who have been in previous studies.
For: Severe Alopecia AreataUnited States · China · Czechia